Caveolin-1 Expression in the Dorsal Striatum Drives Methamphetamine Addiction-Like Behavior

Area of Science:

• Neuroscience
• Molecular Biology
• Addiction Research

Background:

• Dopamine D1 receptor (D1R) function is modulated by caveolin-1 (Cav1), a protein found in lipid rafts.
• Methamphetamine is an indirect agonist of D1Rs and its self-administration is a key model for studying addiction.

Purpose of the Study:

• To investigate the role of dorsal striatal caveolin-1 (Cav1) expression in modulating methamphetamine self-administration and addiction-like behaviors.
• To explore the underlying mechanisms involving striatal plasticity and signaling pathways.

Main Methods:

• Utilized lentiviral vectors to overexpress (LV-Cav1) or knockdown (LV-shCav1) Cav1 in the dorsal striatum of rats.
• Assessed methamphetamine and sucrose self-administration under fixed-ratio, dose-response, and progressive-ratio schedules.
• Confirmed Cav1 expression changes via Western blotting.
• Evaluated high-frequency stimulation (HFS)-induced long-term potentiation (LTP) in the dorsal striatum using electrophysiology.

Main Results:

• Overexpression of Cav1 enhanced methamphetamine self-administration and induced a drug-vulnerable phenotype.
• Knockdown of Cav1 reduced methamphetamine self-administration and induced a drug-resistant phenotype.
• Cav1 manipulation did not affect sucrose self-administration.
• Cav1 overexpression prevented methamphetamine-induced occlusion of striatal plasticity by increasing CaMKII phosphorylation.
• Cav1 knockdown impaired HFS-induced LTP, rendering striatal plasticity resistant to methamphetamine's effects.

Conclusions:

• Dorsal striatal Cav1 expression levels critically modulate addiction vulnerability and resistance.
• Cav1 influences drug reward by regulating striatal plasticity and associated signaling pathways.
• Targeting Cav1 presents a potential therapeutic strategy for psychostimulant addiction.